The envelope glycoprotein of Ebola virus contains an immunosuppressive-like domain similar to oncogenic retroviruses  by Volchkov, Viktor E. et al.
Volume 305, number 3, !8 l-184 FEBS 11222 
Q 1992 Federation of European Bioshemical Societies 00145793/92/55.00 
July 1992 
The envelope glycoprotein of Ebola virus contains an 
immunosuppressive-like domain similar to oncogenic retroviruses 
Viktor E. Volchkov, Vladimir M. Blinov 2nd Sergey V. Netesav 
Ktlstirrrrc of Molmrfar Biology, Kd~sovo, 633159 Ntmsibirsk Region, Russicr 
Reccivcd 7 May 1992 
Genomic RNA of a Zaire strain of Ebola virus was cloned, and cDNA inserts specilic for the glycoprotcin gene wcrc isolated and sequenced. The 
determined sequence has only one npcn rcading frame encoding 318 amino acids and is part of 0RF-4 on the plus RN.4 strand. The putative 
transcriptional stop site (3’ AAULJCUUUUU 5’) and the transcriptional start site (3’ AACUACUUCUAAUU.. 5’) were idcntificd. Computcr- 
assisted comparison of the amino acid sequence of the C-terminal part of protein encoded by ORE-4 of Ebola virus with scqucnces ofthc proteins 
present in the SWISSPROT and EMBL banks revealed significant homology with the ‘immunosuppressive domain’ ofthc p15E envelope proteins 
of various oncogenic retroviruscs. The possible role of such a homology is discussed. 
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1, 1NTRODUCTION 
Ebola virus is an enveloped, negative-stranded RNA 
virus. This virus belongs to the family Filoviridae and 
has a distinctive morphology similar only to that of 
Marburg virus, but apparently has no antigcnic harac- 
teristics of Marburg virus [1,2]. Its genomc is a non- 
segmented RNA strand with an approximate molecular 
weight of 4.10”. SDS-PAGE profiles demonstrate the 
presence of seven structural proteins. These are the 
major nucleoprotein NP (104 K), glycoprotein GP (125 
K), L protein (180 K), and four proteins: VP40 (40 K), 
‘V’PX (35 K), VP30 (30 K) and VP24 (24 K). All the 
proteins are encoded by monocistronic mRNA tran- 
scripts complementary to virion RNA [3,4]. GP is the 
major protein of the surface spikes. and only this 125 
K viral protein is glycosylatcd [3,5]. 
To better understand the nature of this exclusively 
pathogenic agent of a human infectious disease, it k 
necessary to study the organization of Ebola virus 
genome.-In this paper we pt!&ent cloning and sequenc- 
ing data of the fragment of virion RNA encoding the 
C-terminus of the G-protein. In addition we compare 
this region with sequences from EMBL and SWISS- 
PRGT banks and reveal that it has homology with the 
‘inmxn~osuppressive domain’ of oncogenic retroviruscs. 
2. MATERIALS AND METHODS 
The Mayinpt strain of Ebola virus (a Zaire subtype) had been 
obtained from the Byclorussian Institute of Microbiology and Epi- 
dcmiolopy (Minsk. USSR) and was onzc passaged in bfaruru rhws 
before USC. The virus was cultured in Vcro cells and purified from the 
tissue culture liquid as dcscribcd previously [3-51. The virus was resus- 
pended in TNE and used for RNA extraction. Extraction of virion 
RNA was carried out as described in [(il. The ftrst-strand cDNA 
synthesis on viral RNA templates was primed with a random primer 
using RT. RNA-cDNA hydrids wcrc poly(dC)-tailed and cloned in 
Psrl digested poly(dCi)-tailcsdvector plasmid pBR322. Recombinant 
plasmids with the longest prolonged cDNA inserts were identified by 
in situ colony hybridization. DNA sequences were dacrmincd accord- 
ing to Maxam and Gilbert [7]. Homology starch through SWIS- 
SPROT or the EMI3L bank was pcrformcd using the QUICK pro- 
gram of the GENEBEE packap. 
3. RESULTS AND DISCUSSlON 
Standard gene-engineering techniques were used to 
obtain a wide collection of recombinant clones contain- 
ing inserts of cDNA specific for Ebola virus. Seven 
partly overlapping inserts of cDNA containing more 
than 90% of virion RNA sequence were chosen for nu- . 
cleotide sequencing. 
Abbre~~iuriorrs: ARV, avian rcticulocndothcliosis virus (rctrovirus); 
FcLV, feline leukemia virus (rctrovirus); R5V, Rous sarcoma virus 
(retrovirus); ASV, avian sarcoma virus (retrovirus); DAEV. baboon 
Here we present he partial nucleotide sequence of 
Y-end of the ORF-4-encoding ene (1,194 bp) from the 
plus RNA-strand (Fig. 1). This nucleotide sequence was 
endogenous virus (relrovirus); HTLVIC, human T-cell leukemia virus 
type I; MTLV2. human T-cell ieukemia virus type II (retrovirus). 
determined by sequencing the inserts of pEbl37 and 
pEblO2 plasmids (more than 95% of the DNA sequence 
Corresportrhce uddress: V.E. Volchkov. Institute of Molecular Biol- 
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642 974. 
was determined for both strands). The full-length se- 
quence of the Ebola virus genome will soon be pub- 
lished elsewhere. 
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Fig. 1. Nuclcotide sequence of 1,194 bp of the part of viral inserts in 
pEB137 and pEBIO?. The sequence represented is the positive anti- 
gnome strand in the DNA form, The possible translation product is 
indicated. The one-letter code for abbreviating amino acids is used, 
Potentiul glycosylation sites are denoted by single lines under each of 
the tripeptidc sequences. The stop and start transcription signals are 
indicated by the single and double underlines. respectively. 
The sequence determined showed that there was only 
one open reading frame, which encoded 3 18 amino 
acids. The tmnscriptional stop site (5’ 
..UUAAGAAAAA 3’) on the 3’-end of the sequence 
was predicted according to its homology with the NP 
gene of Ebola virus [S]. The putative transcriptional 
start site for mRNA-5 (5’ UUGAUGAAGAUUAA 
..3’) was overlapped by the transcriptional stop site of 
mRNA-4 and was identified on the basis of homology 
with the corresponding site of the gene [b]. Similar tran- 
scriptional signals were found for all the seven pro- 
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longed ORFs of the Ebola plus RNA strand (data not 
shown). 
We supposed this sequence to constitute part of the 
GP gene. Recently it was demonstrated that the GP 
protein of a related Ebola virus - Marburg virus - was 
encoded by ORF-4 of the plus RNA strand [9]. Moreo- 
ver, the GP protein of Ebola virus is known to have a 
large molecular weight (:25 K) and is the only viral 
glycoprotein [3,5]. The molecular weight of the protein 
encoded by the predicted ORF-4 is about 75 kDa and 
contains 12 potential asparagine-linked glycosylation 
sites. 7 of them being indicated on the sequence shown 
in Fig. 1. 
There are data indicating a marked depression of the 
immune response observed in Ebola infection of mon- 
keys which is not directly associated with virus repro- 
duction, but obviously depends on ‘humoral factors 
[IO]. One of the proteins of Ebola virus is supposed by 
us to have an immunosuppressive-like domain which 
plays a crucial role in the pathogenesis of this infection. 
The deduced amino acid sequences of all prolonged 
ORFs found on the plus RNA strand of Ebola virus 
were compared with sequences of proteins with im- 
munosuppressive properties present in the SWISS- 
PROT and EMBL banks. This analysis indicated the 
occurrence of a significant level of homology with the 
pl5E proteins of the various oncogenic retroviruses. 
Retroviruses are known to cause a large number of 
animal cancers often associated with immunosuppres- 
sion [I l-141. There is evidence that certain retrovirus 
virion proteins synthesized by infected cells may con- 
tribute to the immunosuppression which has been 
linked to a conserved segment of IS amino acids, the 
so-called *immunosuppressive p ptide”, located within 
the transmembrane component of the envelcpe protein. 
This sequence results in immunodeficiency of the host 
organism by blocking the induction of lymphocytes in 
response to antigens or mitogtns. The immuno-suppres- 
sive propgerties of the envelope protein of Avian reticu- 
loendotheliosis virus (ARV), notably the inhibition of 
the blastogenic response of lymphocytes to Con-A by 
induction of a T-suppressor cell population, are well 
described [I 53. A synthetic peptide representing 14 
amino acids of Feline leukemia virus (FeLV) p?SE is 
known to inhibit the proliferation of lymphoiti cells in 
vitro [16]. Furthermore, the disrupted Baboon en- 
dogenous virus (BAEV), also sharing the pl5E se- 
quence, is capable of blocking CnA-induced blastogene- 
sis of human lymphocytes [ 173. 
We compared the amino acid sequences of the enve- 
lope proteins of ARV, RSV, ASV, BAEV, HTLVlC 
and HTLV2 [ 1 S-231 with the sequence of the C-terminal 
part of the protein encoded by 0RF-4 of Ebola virus. 
As shown in Fig. 2, the homologous regions between 
Ebola virus and retroviruses involve 160 residues, in- 
cluding six cysteine residues. Over this region the enve- 
lope polyproteins of retroviruses and Ebola virus ex- 
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Fig. 2. Amino acid scquencc alignment of the C-terminal 0RF-4 of Ebola virus and pl5E-rclalcd promins of Rous SarCOmil virus (RSV), Avian 
sarcoma virus (ASV), ARV, BAEV, Human T-cell leukemia virus type I (HTLVIC) and HTLVI. Dols indicate amino acid rcsiducs identical or 
belonging to the same group of chemical similarity as Ebola virus. The amino acid families arc separated by us as follows: (P,G.S,T,A); 
(F,Y,W,I,L,M,V); (D,E,N,Q); (K,R,H); (C). Gaps arc introduced LO maximix homology. The one-leucr code is used IO abbrcviam amino acids. 
Residues identical for all proteins arc marked by asterisks. The immunosuppressive domain is denoted by single lines. 
hibit 24-44 identities, but this optimal alignment re- 
quires the insertion of IO-12 gaps. In spite of the amino 
acid sequence divergence, these proteins exhibit a num- 
ber of structural similarities. Firstly, as shown in Fig. 
2, the immunosuppressive domain of retroviruses and 
the similar domain of Ebola virus (residues 227-252) 
have high homology (3846%). Secondly, the greater 
part of the amino acid substitutions is conserved, and 
moreover, retroviruses and Ebola virus share potential 
sites of glycosylation in these regions. Three cysteine 
residues in this region are also conserved, which sug- 
gests similar patterns of disulfide bonding. 
Hypothetical models of the association of plSE-re- 
fI B 
Fig, 3. The model of a possible structure of ihc envelope polyprotcins 
such as that of the rciroviruscs [24] (A), and the C-terminus of the 
glycoprotein of Eboia virus (B) lo the hydrophobic part of the mem- 
brane. Three hydrophobic regions arc denoted by the black boxes. 
lated proteins of retroviruses and the C-terminus of the 
ORF-4 protein (gGPC) with the membrane are similar 
(Fig. 3). This is confimled by calculating the hydropho- 
bicity index. In this model the main part of pl5E protein 
and pGPC is located outside the lipid portion of the 
membrane and anchored to the membrane via a hydro- 
phobic sequence near the carboxyl terminus. 
Therefore we offer as a working hypothesis that the 
presence of such a well-conserved region occurring in 
the envelope proteins of retroviruses and Ebola virus 
may be accounted for by recombination between the 
viral RNAs. The evolutionary implications of this hy- 
pothesis is discussed but RNA recombination has been 
reported for different viruses [24]. 
For the similarity of the envelope proteins of retro- 
viruses and the protein encoded by 0RF-4 of Ebola 
virus, it is possible that a similar mechanism might be 
functional in the pathogenicity of these viruses. It re- 
mains to be determined whether the immunosuppres- 
sive domain is located on the outside membrane of virus 
particles and virus-infected cells and wether it plays a 
role in pathogenicity of Ebola virus infection. 
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